(Q42648818)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20149736%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20149736%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20149736%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

David M Thomas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20149736%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Robert Henshaw

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20149736%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Keith Skubitz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20149736%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Sant Chawla

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20149736%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Arthur Staddon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20149736%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Martine Roudier

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20149736%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Judy Smith

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20149736%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Zhishen Ye

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20149736%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Winnie Sohn

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20149736%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Roger Dansey

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20149736%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Susie Jun

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20149736%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

10 February 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20149736%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20149736%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20149736%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20149736%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

275-280

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20149736%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

cites work

Giant cell tumor of bone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

Giant-cell tumour of bone.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

Treatment options for recurrent giant cell tumors of bone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

Benign giant cell tumor of bone with osteosarcomatous transformation ("dedifferentiated" primary malignant GCT): report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

Long-term follow-up of patients with giant cell tumor of the sacrum treated with selective arterial embolization

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

Serial arterial embolization for large sacral giant-cell tumors: mid- to long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

Giant-cell tumour of bone metastasising to the lungs. A long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

Bisphosphonates may reduce recurrence in giant cell tumor by inducing apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: A case–control study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

Extended efficacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

Malignancy in giant cell tumor of bone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970010-3

7 January 2021

10.1016/S1470-2045(10)70010-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20149736%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference